2019 logo_150x35_jpg.jpg
Novan Moves Forward with Unified Corporate Branding
March 08, 2023 09:00 ET | Novan, Inc.
– Novan is a fully integrated pharmaceutical company with proven capabilities across drug development through to commercialization – – EPI Health adopts Novan corporate branding, creating unified...
2019 logo_150x35_jpg.jpg
FDA Accepts Novan’s NDA for Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum with a PDUFA Goal Date of January 5, 2024
March 07, 2023 08:00 ET | Novan, Inc.
– FDA completes filing review of application with no filing issues identified – – New Chemical Entity (“NCE”) has potential to be the first FDA-approved prescription product for molluscum in the...
2019 logo_150x35_jpg.jpg
Novan to Present at the Virtual Investor 2023 Companies to Watch Event
January 18, 2023 08:05 ET | Novan, Inc.
DURHAM, N.C., Jan. 18, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive Officer of Novan, will...
Variety of new Stonewall Kitchen Products for January 2023
Stonewall Kitchen Announces New January 2023 Product Launch
January 09, 2023 01:00 ET | Stonewall Kitchen
YORK, Maine, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Stonewall Kitchen and its family of brands are pleased to announce their new January product launch, which introduces over 50 new items into the...
2019 logo_150x35_jpg.jpg
Novan Submits New Drug Application to the U.S. FDA for Berdazimer Gel, 10.3% (SB206) for the Treatment of Molluscum Contagiosum
January 06, 2023 08:00 ET | Novan, Inc.
– Potential FDA approval anticipated in first quarter 2024, assuming the filing is accepted by the FDA and under standard review timelines – – Molluscum contagiosum is a viral skin infection that...
2019 logo_150x35_jpg.jpg
EPI Health, a Novan Company, Enters into Exclusive License Agreement with Sato Pharmaceutical Co., Ltd. for RHOFADE® in Japan
December 21, 2022 08:00 ET | Novan, Inc.
DURHAM, N.C., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that EPI Health, LLC, a fully consolidated subsidiary of Novan, has entered...
AccurioShine 3600 with iFoil One
Konica Minolta lance l’AccurioShine 3600 avec iFoil One
December 14, 2022 11:00 ET | Solutions d’affaires Konica Minolta (Canada) Ltée
MISSISSAUGA, Ontario, 14 déc. 2022 (GLOBE NEWSWIRE) -- Solutions d’affaires Konica Minolta (Canada) Ltée (Konica Minolta), chef de file des solutions d’impression et d’emballage industrielles...
AccurioShine 3600 with iFoil One
Konica Minolta Launches AccurioShine 3600 + iFoil One
December 14, 2022 11:00 ET | Konica Minolta Business Solutions (Canada) Ltd.
MISSISSAUGA, Ontario, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Konica Minolta Business Solutions (Canada) Ltd. (Konica Minolta), a leader in industrial and commercial printing and packaging solutions,...
2019 logo_150x35_jpg.jpg
EPI Health, a Novan Company, Executes a $15.0 Million Financing Agreement
December 02, 2022 08:00 ET | Novan, Inc.
– Agreement provides immediate access to cash flow – – EPI Health leveraging accounts receivables from commercial product sales to bolster working capital needs – DURHAM, N.C., Dec. 02, 2022 ...
2019 logo_150x35_jpg.jpg
Novan to Participate in the Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & Medtech Conference
December 01, 2022 09:00 ET | Novan, Inc.
– Paula Brown Stafford, President and Chief Executive Officer of Novan to participate in a live moderated panel discussion on Thursday, December 8th at 11:00 AM ET – DURHAM, N.C., Dec. 01, 2022 ...